Senior insider sale
EVP & Co-Head Research & Inv. at ROYALTY PHARMA PLC — senior position signals high conviction
$726.1K
13.68K shares
What this filing means
URIST MARSHALL plans to sell 13.68K shares of ROYALTY PHARMA PLC valued at approximately $726.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/14/2026ACC: 0001964306-26-000239
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
13.68K
Shares to sell
$726.1K
Approx. market value
13.68K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Equity Performance Award
Granted as part of issuer equity compensation program
2/11/2026
6.29KEquity Performance Award
Granted as part of issuer equity compensation program
11/5/2025
4.63KEquity Performance Award
Granted as part of issuer equity compensation program
8/6/2025
2.77KTotal acquired13.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Equity Performance Award Granted as part of issuer equity compensation program | 6.29K | — |
11/5/2025 | Equity Performance Award Granted as part of issuer equity compensation program | 4.63K | — |
8/6/2025 | Equity Performance Award Granted as part of issuer equity compensation program | 2.77K | — |
| Total | 13.68K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.68K
Market value
$726.1K
5/14/2026
Total
Units
13.68K
Value
$726.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/14/2026 | 13.68K | $726.1K | NASDAQ | Planned |
| Total | 13.68K | $726.1K | ||